ADVERSE EVENTS FOLLOWING PENTAVALENT VACCINE ADMINISTRATION: A DESCRIPTIVE STUDY IN THE INDIAN CONTEXT
Kejadian Ikutan Pasca Imunisasi (KIPI) Setelah Pemberian Vaksin Pentavalen: Studi Deskriptif dalam Konteks India
Downloads
Background: Immunization is one of the best ways to prevent childhood diseases. The pentavalent vaccine protects against five serious illnesses with fewer injections. It is cost-effective and usually causes fewer adverse events following immunization (AEFI). However, there are still limited data on AEFI after giving the pentavalent vaccine, compared to giving the DPT, Hep-B, and Hib vaccines separately. Purpose: To determine the proportion and factors associated with adverse events following immunization with pentavalent vaccines. Methods: This was a descriptive study conducted at an immunization clinic in a tertiary care center in India between January 2023 and December 2023. The study population consisted of all infants attending the clinic for vaccination, and all eligible infants receiving pentavalent vaccines were included in the study. The study was done to understand the frequency and type of AEFIs and to ensure the vaccine safety. Results: A total of 93 infants were included in this study, and 264 adverse events were noted in our study. Fever was the most common presenting adverse effect (22.73 %), other adverse effects were pain at injection site (21.21%), swelling at injection site (15.53%), redness at site of injection (14.39%), 10.60% held their leg back due to pain, persistent crying (9.47%) and abscess formation (4.55 %.), and seizures (1.52%). Conclusion: Most of the adverse effects observed in present study were of mild nature and of non-serious type. No major AEFI or permanent damage was noted in our study. The benefits of vaccination far outweigh the risks.
Mittal S, Rawat C, Gupta A, et al. (April 30, 2023) Adverse Events Following Immunization among Children Under Two Years of Age: A Prospective Observational Study from North India. Cureus 15(4): e38356. doi:10.7759/cureus.38356
Lindstrand A, Cherian T, Chang-Blanc D, Feikin D, O’Brien KL. The world of immunization: achievements, challenges, and strategic vision for the next decade. The Journal of Infectious Diseases. 2021 Oct 1; 224 (Supplement_4):S452-67.
Who.int. [cited 2024 Sep 17]. Available from: https://cdn.who.int/media/docs/default-source/searo/india/tobacoo/pentavalent-vaccine-guide-for-hws-with-answers-to-faqs.pdf
Li X, Mukandavire C, Cucunubá ZM, Londono SE, Abbas K, Clapham HE, Jit M, Johnson HL, Papadopoulos T, Vynnycky E, Brisson M. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. The Lancet. 2021 Jan 30;397 (10272):398-408.
Government of India. Ministry of Health and Family Welfare. National Health Policy 2017. New Delhi: Ministry of Health and Family Welfare; 2017. Available from: [https://main.mohfw.gov.in/]
Das M, Kumar M, Poluru R, Phd Kashyap N, Kumar B, Thomas M, et al. MD;INCLEN Vaccine Safety Study Group. A Prospective Cohort Study on the Safety of Infant Pentavalent (DTwP-HBV-Hib) and Oral Polio Vaccines in Two South Indian Districts. The Pediatric Infectious Disease Journal. 2020; 39 (5):389–96.
Das MK. Adverse events following immunization-the known unknowns and black box: based on 10th Dr. IC Verma excellence award for young pediatricians delivered as oration on 9th Oct. 2022. Indian Journal of Pediatrics. 2023 Aug; 90 (8):817-25.
Maizare HI, Tsiga-Ahmed FI, Jibo AM, Adamu AL, Jalo RI, Magaji A, Ibrahim UA, Gajida AU. Prevalence and patterns of adverse events following immunisation among children less than 24 months attending immunisation clinics in Kano, Nigeria. Annals of African Medical Research. 2021 Dec 27; 4 (1).
Dixit P, Prashant P, Gera V, Bansal A. AEFI (adverse events following immunization) among children less than 2 years following pentavalent vaccine - a cross-sectional study in India. J Popul Ther Clin Pharmacol. 2024; 31(3):136–44.
Xavier S, Mazumder D, Kumar M. A mixed cohort study on adverse events following pentavalent vaccine and its perception among parents. Int J Curr Pharm Rev Res. 2023;15 (12):470-4.
Pan X, Lv H, Liang H, Wang Y, Shen L, Chen F, Chen Y, Hu Y. Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China. Human Vaccines & Immunotherapeutics. 2022 Jan 31; 18 (1):2021711.
Izadi S, Mohammadi M, Sartipi M, Karami M, Karimi H. Acute adverse events following immunization with DTP-HB-Hib pentavalent vaccine in the first year of life. Eastern Mediterranean Health Journal. 2023; 29 (1):6-14.
Sharma N, Pugazhendi S, Semwal J, Prakash K. Adverse events following immunization among children during primary immunizations in selected health facility of Himachal Pradesh. Indian Journal of Community Health. 2023 Dec 31;35 (4):502-9.
Ekrami Noghabi M, Saffar MJ, Rezai S, Saffar H, Saffar H, Hosseinzadeh F, Nadi Ghara A, Rezai MS. Immunogenicity and complications of the pentavalent vaccine in Iranian children. Frontiers in Pediatrics. 2021 Oct 1; 9:716779.
Bansal S, Mahajan RC. Adverse events following immunization with pentavalent vaccine in a tertiary care hospital. Int J Contemp Pediatr. 2018;5 (1):82-4.
Khatereh A, Koruosh G, Alireza T, Daryuosh J, Parastoo B. Adverse Events Following Immunizations in Infants Under 1 Year of Age in Lorestan Province, Western Iran. Journal of Preventive Medicine and Public Health. 2023 Mar; 56 (2):172.
Khazaei Z, Moradi G, Zahraei SM, Gouya MM, Goodarzi E, Yaghini F, Roshani D. The comparison of the adverse events of pentavalent vaccine and DPT vaccine in 2–6 months infants in Iran: a national study. Annals of Global Health. 2020; 86 (1).
Karami M, Ameri P, Bathaei J, Berangi Z, Pashaei T, Zahiri A, Zahraei SM, Erfani H, Ponnet K. Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran. BMC immunology. 2017 Dec;18:1-7.
Paramkusham V, Palakurthy P, sri Gurram N, Talla V, Vishwas HN, Jupally VR, Pattnaik S. Adverse events following pediatric immunization in an Indian city. Clinical and Experimental Vaccine Research. 2021 Sep;10(3):211.
Ma'rifati LL, Udijono A, Kusariana N. Barrier perception factors affecting the acceptance of the COVID-19 vaccine in Salatiga City. Periodic Epidemiology Journal/Jurnal Berkala Epidemiologi. 2023 Jan 1;11(1).
- Every manuscript submitted to must observe the policy and terms set by the Jurnal Berkala Epidemiologi
- Publication rights to manuscript content published by the Jurnal Berkala Epidemiologi is owned by the journal with the consent and approval of the author(s) concerned. (download copyright agreement)
- Complete texts of electronically published manuscripts can be accessed free of charge if used for educational and research purposes according to copyright regulations.
JBE by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
